Bin Li, Qi Xiao, Hongmei Zhao, Jianuo Zhang, Chunyan Yang, Yucen Zou, . . . Haitao Liu. (2024). Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism. Elsevier.
Chicago Style (17th ed.) CitationBin Li, et al. Schisanhenol Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting MiR-802 Activation of AMPK-mediated Modulation of Hepatic Lipid Metabolism. Elsevier, 2024.
MLA (9th ed.) CitationBin Li, et al. Schisanhenol Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting MiR-802 Activation of AMPK-mediated Modulation of Hepatic Lipid Metabolism. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.